UY35622A - MODULATORS OF ESTROGEN RECEIVERS AND THEIR USES - Google Patents

MODULATORS OF ESTROGEN RECEIVERS AND THEIR USES

Info

Publication number
UY35622A
UY35622A UY35622A UY35622A UY35622A UY 35622 A UY35622 A UY 35622A UY 35622 A UY35622 A UY 35622A UY 35622 A UY35622 A UY 35622A UY 35622 A UY35622 A UY 35622A
Authority
UY
Uruguay
Prior art keywords
estrogen
modulators
receivers
compounds
estrogen receptors
Prior art date
Application number
UY35622A
Other languages
Spanish (es)
Inventor
Kahraman Mehmet
Steven P Govek
Nicholas D Smith
Original Assignee
Seragon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seragon Pharmaceuticals Inc filed Critical Seragon Pharmaceuticals Inc
Publication of UY35622A publication Critical patent/UY35622A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos que son moduladores de los receptores de estrógeno. Composiciones farmacéuticas y medicamentos que los comprenden. Métodos para usarlos, solos o en combinación con otros compuestos, en el tratamiento de aquellas enfermedades y aquellas afecciones que están mediadas por los receptores de estrógeno o que dependen de los receptores de estrógeno.Compounds that are estrogen receptor modulators. Pharmaceutical compositions and medications that comprise them. Methods for using them, alone or in combination with other compounds, in the treatment of those diseases and conditions that are mediated by estrogen receptors or that depend on estrogen receptors.

UY35622A 2013-06-19 2014-06-18 MODULATORS OF ESTROGEN RECEIVERS AND THEIR USES UY35622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361836901P 2013-06-19 2013-06-19

Publications (1)

Publication Number Publication Date
UY35622A true UY35622A (en) 2014-12-31

Family

ID=52479011

Family Applications (1)

Application Number Title Priority Date Filing Date
UY35622A UY35622A (en) 2013-06-19 2014-06-18 MODULATORS OF ESTROGEN RECEIVERS AND THEIR USES

Country Status (3)

Country Link
AR (1) AR096678A1 (en)
MA (1) MA38658A1 (en)
UY (1) UY35622A (en)

Also Published As

Publication number Publication date
AR096678A1 (en) 2016-01-27
MA38658A1 (en) 2017-10-31

Similar Documents

Publication Publication Date Title
CR20150664A (en) MODULATORS OF ESTROGEN RECEIVERS AND THEIR USES
CL2018001172A1 (en) CD80 extracellular domain polypeptides and their use in cancer treatment
CL2018000883A1 (en) Farnesoid x receiver modulators
CL2016003056A1 (en) Sting modulating cyclic dinucleotides; Composition and pharmaceutical combination that includes them and their use for the treatment of diseases such as inflammation, allergic and autoimmune diseases, infectious diseases and cancer.
MX2015011132A (en) Polycyclic estrogen receptor modulators and uses thereof.
CL2017001289A1 (en) Fused bicyclic compounds, their compositions and their use for the treatment of diseases related to the modulation of the x-farnesoid receptor (fxr).
CL2016002772A1 (en) Fast-acting insulin compositions
DOP2017000124A (en) INSULIN RECEPTOR PARTIAL AGONISTS
CL2016000153A1 (en) Glioxamide substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis b
CL2015002125A1 (en) Modulators of nmda receptors of spiro-lactam and their uses.
MX2015016171A (en) Azetidine estrogen receptor modulators and uses thereof.
EA201791310A1 (en) CHEMERIC ANTIGEN RECEPTORS TO BCMA
CL2018000819A1 (en) Bispecific anti-human cd20 antibodies / human transferrin receptor and methods for use
MX2016011636A (en) Therapeutic combinations with estrogen receptor modulators.
CL2015002123A1 (en) Modulators of spiro-lactam nmda receptors and their uses
EA201491161A1 (en) FLUORINATED ESTROGEN RECEPTOR MODULATORS AND THEIR APPLICATION
ECSP16078782A (en) ISOINDOLINONE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
UY36075A (en) TUBULISINE DERIVATIVES
AR104664A1 (en) CONJUGATES OF DRUGS WITH ANTIBODIES AGAINST CADHERINE 6 (ANTI-CDH6)
CL2015000976A1 (en) Compounds of 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine for use in the treatment of diabetes and its associated disorders.
CL2016000009A1 (en) Papulopustular rosacea treatment with ivermectin.
CL2017002170A1 (en) Deacetoxytubulysin h and analogs thereof.
CL2017003147A1 (en) Nuclear receiver modulators
CL2016002809A1 (en) Compounds derived from pyrrole, pyridine or piperidine substituted with heterocycles, modulators of the protein-coupled receptor g 40 (gpr40); pharmaceutical composition comprising them; and its use for the treatment of diseases such as diabetes, retinopathy, neuropathy, atherosclerosis, obesity and hypertension.
CO2017002472A2 (en) Abiraterone acetate formulation

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211206